Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study

Daopeng Dai,Chunkai Huang,Hui Han,Ruiyan Zhang,Jinwei Ni,Jinzhou Zhu,Zhenbin Zhu

doi:10.1038/s41598-019-47367-2

Daopeng Dai, Chunkai Huang + Show 5 more

Open Access

https://doi.org/10.1038/s41598-019-47367-2

Copy DOI

Journal: Scientific Reports	Publication Date: Jul 25, 2019
Citations: 2	License type: open-access

Affiliation: Shanghai Jiao Tong University

Abstract

Recent evidence has indicated that the lymphatic vessel endothelial hyaluronan receptor (LYVE-1) is implicated in chronic inflammation and the lymphatic immune response. The soluble form of LYVE-1 (sLYVE-1) is produced by ectodomain shedding of LYVE-1 under pathological conditions including cancer and chronic inflammation. In this study, 1014 consecutive patients who underwent coronary angiography from May 2015 to September 2015 were included to investigate whether serum sLYVE-1 is associated with coronary artery disease (CAD) and its concomitant diseases includes chronic kidney disease (CKD). Results showed that there was no significant difference in sLYVE-1 levels between patients with CAD and without. However, a significantly higher level of sLYVE-1 was seen in patients with renal dysfunction compared to those with a normal eGFR. Results were validated in a separate cohort of 259 patients who were divided into four groups based on their kidney function assessed by estimated glomerular filtration rate (eGFR). Simple bivariate correlation analysis revealed that Lg[sLYVE-1] was negatively correlated with eGFR (r = −0.358, p < 0.001) and cystatin C (r = 0.303, p < 0.001). Multivariable logistic regression analysis revealed that the increase in Lg[sLYVE-1] was an independent determinant of renal dysfunction (odds ratio = 1.633, p = 0.007). Therefore, renal function should be considered when serum sLYVE-1 is used as a biomarker for the detection of pathological conditions such as chronic inflammation and cancer. Further study is required to elucidate the exact role of sLYVE-1 in renal function.

Highlights

The lymphatic system, known as the second circulatory system, is indispensable in draining interstitial fluid from tissues and returning it to blood circulation[1]
We aimed to investigate whether serum soluble LYVE-1 (sLYVE-1) is related to coronary artery disease (CAD) as well as its concomitant diseases including hypertension, dyslipidemia, diabetes, and chronic renal dysfunction, all of which are known to be conditions associated with chronic inflammation[16,17,18,19,20]
Patients were further trisected into 3 groups according to serum sLYVE-1 levels (Table 2)

Summary

Introduction

The lymphatic system, known as the second circulatory system, is indispensable in draining interstitial fluid from tissues and returning it to blood circulation[1]. Studies have shown that acute inflammatory reactions and chronic inflammatory diseases are accompanied by both the expansion of preexisting lymphatic vessels (lymphatic hyperplasia) and the growth of new lymphatic vessels (lymphangiogenesis), indicating a role for the lymphatic system in immune surveillance and the inflammatory process, including that which arises in the context of coronary artery disease (CAD)[2,3,4,5,6]. Given the important role of the lymphatic system in reversing cholesterol transport during the development of atherosclerosis, an association between serum sLYVE-1 levels and CAD severity was hypothesized[14,15]. We aimed to investigate whether serum sLYVE-1 is related to CAD as well as its concomitant diseases including hypertension, dyslipidemia, diabetes, and chronic renal dysfunction, all of which are known to be conditions associated with chronic inflammation[16,17,18,19,20]

Objectives

Methods

Results

Conclusion